- Home
- FDMT vs SPPP Comparison
FDMT vs SPPP Comparison
Compare FDMT & SPPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- SPPP
- Stock Information
- Founded
- FDMT 2013
- SPPP 2011
- Country
- FDMT United States
- SPPP Canada
- Employees
- FDMT N/A
- SPPP N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- SPPP
- Sector
- FDMT Health Care
- SPPP
- Exchange
- FDMT Nasdaq
- SPPP NYSE
- Market Cap
- FDMT 161.7M
- SPPP 172.2M
- IPO Year
- FDMT 2020
- SPPP N/A
- Fundamental
- Price
- FDMT $3.75
- SPPP $10.31
- Analyst Decision
- FDMT Buy
- SPPP
- Analyst Count
- FDMT 10
- SPPP 0
- Target Price
- FDMT $32.33
- SPPP N/A
- AVG Volume (30 Days)
- FDMT 448.3K
- SPPP 183.3K
- Earning Date
- FDMT 05-08-2025
- SPPP 01-01-0001
- Dividend Yield
- FDMT N/A
- SPPP N/A
- EPS Growth
- FDMT N/A
- SPPP N/A
- EPS
- FDMT N/A
- SPPP N/A
- Revenue
- FDMT $23,000.00
- SPPP N/A
- Revenue This Year
- FDMT $13,097.30
- SPPP N/A
- Revenue Next Year
- FDMT N/A
- SPPP N/A
- P/E Ratio
- FDMT N/A
- SPPP N/A
- Revenue Growth
- FDMT N/A
- SPPP N/A
- 52 Week Low
- FDMT $2.24
- SPPP $8.55
- 52 Week High
- FDMT $28.93
- SPPP $11.39
- Technical
- Relative Strength Index (RSI)
- FDMT 57.33
- SPPP 65.45
- Support Level
- FDMT $3.37
- SPPP $10.05
- Resistance Level
- FDMT $3.81
- SPPP $10.25
- Average True Range (ATR)
- FDMT 0.27
- SPPP 0.13
- MACD
- FDMT 0.03
- SPPP 0.03
- Stochastic Oscillator
- FDMT 82.02
- SPPP 85.38
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About SPPP SPROTT PHYS PLATINUM & PALLADIUM
Sprott Physical Platinum & Palladium Tr invests and holds all of its assets in physical platinum and palladium bullion. The company seeks to provide a secure, convenient, and exchange-traded investment alternative for investors interested in holding physical platinum and palladium bullion without the inconvenience that is typical of a direct investment in physical bullion. The Trust invests mainly in long-term holdings of unencumbered, fully allocated, physical platinum and palladium bullion.